Clinical Trial Update: Positron Emission Tomography (PET) Guided Stereotactic Body Radiation Therapy for the Treatment of Oligoprogressive Non-small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating PET-guided stereotactic body radiation therapy for oligoprogressive disease in non-small cell lung cancer, melanoma, and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma
• Non-small Cell Lung Cancer
• Renal Cell Carcinoma

Snippet

Sponsor: City of Hope Medical Center | Conditions: Lung Non-Small Cell Carcinoma, Malignant Solid Neoplasm | Phase 2 | Status: RECRUITING